about
The challenge of developmental therapeutics for adrenocortical carcinomaA Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.Feminizing Adrenocortical Carcinoma with Distant Metastases: Can Surgery be Considered?Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies.Development of adrenal cortex zonation.Adrenocortical carcinoma: the management of metastatic disease.Androgen secreting giant adrenocortical carcinoma with no metastases: A case report and review of the literature.Transcriptomic characterization of fibrolamellar hepatocellular carcinoma.Synthetic high-density lipoprotein nanoparticles: A novel therapeutic strategy for adrenocortical carcinomas.Mouse models of adrenocortical tumors.Prognostic Factors for Adrenocortical Carcinoma Outcomes.Clinicopathological correlates of adrenal Cushing's syndrome.Diagnosis, treatment and outcome of adrenocortical cancer.Methylation Status of Vitamin D Receptor Gene Promoter in Benign and Malignant Adrenal Tumors.Novel Insights into the Genetics and Pathophysiology of Adrenocortical Tumors.Cushing's syndrome: an update on current pharmacotherapy and future directions.Proteome analysis of adrenal cortical tumors.Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma.Challenges in surgical pathology of adrenocortical tumours.Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis.Ectopic, retroperitoneal adrenocortical carcinoma in the setting of Lynch syndrome.A case of adrenocortical carcinoma accompanying secondary acute adrenal hypofunction postoperation.The Characteristics and Trends in Adrenocortical Carcinoma: A United States Population Based Study.Therapeutic Targets for Adrenocortical Carcinoma in the Genomics Era
P2860
Q28072970-301CA133-5871-42A6-B566-04AC994D2A5DQ30252766-33739A24-7CDF-4313-9A94-4CD8758C346DQ33570215-797FE6B8-0A69-479D-B0D7-5147971FBB18Q34366006-6D261A0D-E146-4C6A-A559-5FA218E3247EQ34431264-C5E490E0-D660-4BAE-8456-CDA0109A1FB3Q35800278-CE9E375D-8658-44E4-AA19-E4EBDB527634Q36081865-6830E198-197B-498E-8995-77F93C53A2C8Q36090257-D339A1FD-BCBE-4E87-A13E-2C87822A2DA1Q36268536-A748A31B-260B-413A-9721-59155DED2961Q36451884-E9A5D3C1-57B5-48FD-8F71-A246DB302B6DQ36482758-DA87D3A9-F3CC-4AD7-BCCE-795DAE876F8BQ37121022-4B68BAF1-B8E3-450E-891F-50E5F923DFF3Q38271545-92C610E0-FDCD-4795-B9EA-6BE58B58918FQ38358503-B3B47294-3175-434B-B631-5E4D48C69CD7Q38382378-A86E643B-1A9F-4038-9FFD-F3ECE9959A15Q38536557-C16C9856-2C79-44AC-9BF7-8C29EE79617CQ38541695-FB21CF85-601F-4EB3-ABD7-0B08B1866B2CQ38888303-2B21C5C8-8A31-48F9-8991-BD859CE41A86Q39549740-5BE12F47-4665-485A-B830-1221FE85A5D6Q41355414-B6A30716-D3D3-4C40-9062-2FB4A54788C8Q47576824-25D86AE7-E853-45CA-AF29-16C65D0F3789Q48108818-60012E50-89B0-4F92-A2E9-4DB62454E1BFQ49906590-C1311C0A-EB81-467E-838A-A52AAE4C53BFQ55346829-CCF961F2-1976-4308-A1F5-D5B2AB4179C2Q55445959-09196DC4-44F3-495F-AB4C-B1653B036E6BQ58550571-162B91EA-9593-4BE1-98A1-02320641410E
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Genetics and epigenetics of adrenocortical tumors.
@en
type
label
Genetics and epigenetics of adrenocortical tumors.
@en
prefLabel
Genetics and epigenetics of adrenocortical tumors.
@en
P2860
P1476
Genetics and epigenetics of adrenocortical tumors
@en
P2093
Andreas Moraitis
Gary D Hammer
P2860
P356
10.1016/J.MCE.2013.10.028
P577
2013-11-09T00:00:00Z